Conquering Diseases

A Study Of An Investigational Vaccine For Respiratory Syncytial Virus (R S V) In Adults

Description

Seeking men and women 60 years of age for the study of an investigational vaccine against Respiratory Syncytial Virus

Overview

Participants in this trial will be randomly assigned to receive either the investigational vaccine or a placebo (looks like the vaccine, but doesn't contain medication). There will be about 4 clinic visits over 3 years. Visits may include exams, questionnaires, blood draws, nasal swabs, and injections.

What we're hoping for

To determine if the study vaccine, RSVpreF, is safe and effective in preventing RSV infections compared to a placebo.

Additional Information

ClinicalTrials.gov Identifier: NCT05035212

 Principal Investigator

Mary Dawn  Co, MD

University of Massachusetts Medical School

 Study Contact

Melissa  Adams

508-856-4676

melissa.adams@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989